Close Menu

NEW YORK – PerkinElmer reported after the close of the market on Wednesday that its third quarter revenues jumped 36 percent year over year and beat the consensus Wall Street estimates for the top and bottom lines.

For the three months ended Sept. 30, the Waltham, Massachusetts-based firm posted revenues of $964.0 million compared to $706.9 million in the year-ago period. It beat analysts' average estimate of $841.2 million.

Organic revenue growth was 34 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.